<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03257345</url>
  </required_header>
  <id_info>
    <org_study_id>RHM MED1307</org_study_id>
    <nct_id>NCT03257345</nct_id>
  </id_info>
  <brief_title>VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease</brief_title>
  <acronym>VEST</acronym>
  <official_title>VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Southampton NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aintree University Hospitals NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Southampton NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vedolizumab has been approved for the treatment of both ulcerative colitis and Crohn's
      disease. The aim of this study is to capture the early real life UK experience of vedolizumab
      including the outcomes of treatment, describing the patient population treated, drug
      persistence, IBD control PROM, durable remission, tolerance and safety.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 3, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Steroid-free remission</measure>
    <time_frame>Week 56</time_frame>
    <description>Steroid-free remission at one year as defined by an HBI at week 56 of ≤4 or a UCDAI of ≤2</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Remission and response</measure>
    <time_frame>Multiple</time_frame>
    <description>Remission and response rates at week 6, 14, 30 and 54</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Durable remission</measure>
    <time_frame>Multiple</time_frame>
    <description>Durable remission / response i.e. at week 14, 30 and 54</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect of vedolizumab</measure>
    <time_frame>TBC</time_frame>
    <description>Effect of vedolizumab on disease activity as measured by the PRO2, IBD Control PROM, Physician's Global Assessment and biomarkers of disease activity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HES data</measure>
    <time_frame>1 year</time_frame>
    <description>Healthcare usage at 1 year using HES data</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tolerance and safety</measure>
    <time_frame>1 year</time_frame>
    <description>Tolerance and safety of vedolizumab at 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of disease</measure>
    <time_frame>TBC</time_frame>
    <description>Description of the demographics, disease phenotype, disease and treatment history and concomitant medication use of patients receiving vedolizumab</description>
  </secondary_outcome>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Ulcerative Colitis</condition>
  <condition>Crohn's Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with inflammatory bowel disease due to start vedolizumab for the first time as
        part of routine therapy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participants being given vedolizumab as part of routine care, and vedo naïve prior to
             study

          -  Age 18 or over

          -  Written informed consent obtained from patient for participation in the UK IBD
             Registry

        Exclusion Criteria:

          -  Patient unwilling to take part in the UK IBD Registry

          -  Unable to obtain written informed consent

          -  Patient is, in the opinion of the investigator, not suitable to participate in the
             study

          -  Patients with contraindications to the use of vedolizumab
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fraser Cummings, MBChB</last_name>
    <phone>023 8120 8462</phone>
    <email>fraser.cummings@uhs.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cheryl S Booker, BA</last_name>
    <phone>023 8120 3713</phone>
    <email>cheryl.booker@uhs.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Royal Cornwall Hospitals NHS Trust</name>
      <address>
        <city>Truro</city>
        <state>Cornwall</state>
        <zip>TR1 3LJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Old, BSc</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Devon and Exeter NHS Foundation Trust</name>
      <address>
        <city>Exeter</city>
        <state>Devon</state>
        <zip>EX2 5DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tariq Ahmad, MBChB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brighton and Sussex University Hospitals NHS Trust</name>
      <address>
        <city>Brighton</city>
        <state>East Sussex</state>
        <zip>BN2 5BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Smith, MbChB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kingston Hospital NHS Foundation Trust</name>
      <address>
        <city>Kingston</city>
        <state>Greater London</state>
        <zip>KT2 7QB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fiona Donovan, MSc</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Barts Health NHS Trust</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>E1 1BB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaartje Kok, MBBS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>London North West Healthcare NHS Trust</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>HA1 3UJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ailsa Hart, BMBCh</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University College London Hospitals NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>NW1 2BU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stuart Bloom, MBBS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guy's and St Thomas' NHS Foundation Trust</name>
      <address>
        <city>London</city>
        <state>Greater London</state>
        <zip>SE1 9RT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Irving, MBBS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton NHS Foundation Trust</name>
      <address>
        <city>Southampton</city>
        <state>Hampshire</state>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cheryl S Booker, BA</last_name>
      <phone>023 8120 3713</phone>
      <email>cheryl.booker@uhs.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Fraser Cummings, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Hertfordshire Hospitals NHS Trust</name>
      <address>
        <city>Watford</city>
        <state>Hertfordshire</state>
        <zip>WD18 0HB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Landy, MBChB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Maidstone and Tunbridge Wells NHS Foundation Trust</name>
      <address>
        <city>Maidstone</city>
        <state>Kent</state>
        <zip>ME16 9QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bijay Baburajan, MBBS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>United Lincolnshire Hospitals NHS Trust</name>
      <address>
        <city>Grantham</city>
        <state>Lincolnshire</state>
        <zip>NG31 8DG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tariq Mahmood, MBBS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Aintree University Hospital NHS Foundation Trust</name>
      <address>
        <city>Liverpool</city>
        <state>Merseyside</state>
        <zip>L9 7AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith Bodger, MBChB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shrewsbury and Telford Hospital NHS Trust</name>
      <address>
        <city>Shrewsbury</city>
        <state>Shropshire</state>
        <zip>SY3 8XQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Butterworth, MBChB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sheffield Teaching Hospitals NHS Foundation Trust</name>
      <address>
        <city>Sheffield</city>
        <state>South Yorkshire</state>
        <zip>S10 2JF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan Lobo, MBBS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>West Suffolk NHS Foundation Trust</name>
      <address>
        <city>Bury Saint Edmunds</city>
        <state>Suffolk</state>
        <zip>IP33 2QZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Daniel Sharpstone, MB BS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Newcastle upon Tyne Hospitals NHS Foundation Trust</name>
      <address>
        <city>Newcastle Upon Tyne</city>
        <state>Tyne And Wear</state>
        <zip>NE1 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John C Mansfield, MBBS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Royal Wolverhampton NHS Trust</name>
      <address>
        <city>Wolverhampton</city>
        <state>West Midlands</state>
        <zip>WV10 0QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Brookes, MBChB</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Calderdale and Huddersfield NHS Foundation Trust</name>
      <address>
        <city>Huddersfield</city>
        <state>West Yorkshire</state>
        <zip>HD3 3EA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunil Sonwalkar, MBBS</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 17, 2017</study_first_submitted>
  <study_first_submitted_qc>August 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2017</study_first_posted>
  <last_update_submitted>April 6, 2018</last_update_submitted>
  <last_update_submitted_qc>April 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Southampton NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Fraser Cummings</investigator_full_name>
    <investigator_title>Consultant Gastroenterologist</investigator_title>
  </responsible_party>
  <keyword>Real world outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
    <mesh_term>Inflammatory Bowel Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vedolizumab</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

